Attached files

file filename
S-1 - FORM S-1 - Lazuriton Nano Biotechnology (U.S.A.) Inc.2016mar-lazuriton_s1.htm
EX-3.1 - EX-3.1 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-3_1.htm
EX-3.3 - EX-3.3 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-3_3.htm
EX-3.2 - EX-3.2 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-3_2.htm
EX-3.4 - EX-3.4 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-3_4.htm
EX-5.1 - EX-5.1 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-5_1.htm
EX-10.2 - EX-10.2 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-10_2.htm
EX-10.4 - EX-10.4 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-10_4.htm
EX-10.1 - EX-10.1 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-10_1.htm
EX-10.3 - EX-10.3 - Lazuriton Nano Biotechnology (U.S.A.) Inc.ex-10_3.htm
 
Audit • Tax • Consulting •  Financial Advisory 
Registered with Public Company Accounting Oversight Board (PCAOB)
 
 
 
 
 
 
 
 
 
 
 
Lazuriton Nano Biotechnology (U.S.A.) Inc.
10F., No. 341, Sec. 2, Wanshou Rd., Guishan District,
Taoyuan City, 333, Taiwan (Republic of China)





Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption “Experts” and to the use of our report dated December 8, 2015, in the Registration Statement (Form S-1) and related Prospectus of Lazuriton Nano Biotechnology (U.S.A.) Inc.


/s/    KCCW Accountancy Corp
Diamond Bar, California
March 10, 2016